FAQ
Glossary

Fermer

FAQ

Why are some conditions more suitable for gene and cell therapies than others?

There is an approved treatment available for my condition - why can't I receive it?

How to look for approved medicines?

How are medicines developed and approved?

Voir toutes les FAQ

Fermer

Glossary

Adeno-associated virus (AAV)

Adult stem cells

Chimeric Antigen Receptor (CAR)

Voir le glossaire complet

Key MHRA Resources

Guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) on Advanced Therapy Medicinal Products (ATMPs):

MHRA Innovative Licensing and Access Pathway

MHRA's ILAP provides enhanced regulatory and expert support for the development of innovative medicines.

Back to: Key Pathway Resources

Retour en haut de page

Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires